Cargando…

Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment

Psoriasis is a common inflammatory skin disease, which is tightly associated with metabolic disorders. Cholesteryl ester transfer protein (CETP) and sortilin (SORT) are molecules engaged in lipid metabolism of proatherogenic properties. They have been hardly ever studied in psoriasis before. Serum C...

Descripción completa

Detalles Bibliográficos
Autores principales: Nowowiejska, Julia, Baran, Anna, Krahel, Julita A., Kamiński, Tomasz W., Maciaszek, Magdalena, Flisiak, Iwona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032539/
https://www.ncbi.nlm.nih.gov/pubmed/35448527
http://dx.doi.org/10.3390/metabo12040340
_version_ 1784692668084781056
author Nowowiejska, Julia
Baran, Anna
Krahel, Julita A.
Kamiński, Tomasz W.
Maciaszek, Magdalena
Flisiak, Iwona
author_facet Nowowiejska, Julia
Baran, Anna
Krahel, Julita A.
Kamiński, Tomasz W.
Maciaszek, Magdalena
Flisiak, Iwona
author_sort Nowowiejska, Julia
collection PubMed
description Psoriasis is a common inflammatory skin disease, which is tightly associated with metabolic disorders. Cholesteryl ester transfer protein (CETP) and sortilin (SORT) are molecules engaged in lipid metabolism of proatherogenic properties. They have been hardly ever studied in psoriasis before. Serum CETP and SORT concentrations were measured in 33 patients with plaque-type psoriasis before and after 12 weeks of treatment with methotrexate or acitretin. There was no significant difference in CEPT and SORT serum concentrations between patients and controls. Positive correlations between CETP after the treatment with acitretin and activity of transaminases (R = 0.65, R = 0.56, respectively) were noted. CETP was positively related with triglycerides (R = 0.49), glucose (R = 0.54) and CRP (R = 0.64) before the treatment with methotrexate, which all disappeared afterwards. Systemic therapy with methotrexate caused normalization of SORT concentration. There was significant correlation between SORT and WBC (p < 0.01) and CRP (p < 0.05). CETP and SORT cannot be used as individual biomarkers. Nevertheless, they show some interesting relations with other parameters. Increased concentration of CETP perhaps could investigated as a marker of liver side effects of acitretin treatment in psoriatics. SORT could be considered as a new indicator of metabolically induced inflammation in psoriasis. Methotrexate may be preferred in patients with high SORT concentrations. Further studies are needed to establish their exact role in psoriatic patients.
format Online
Article
Text
id pubmed-9032539
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90325392022-04-23 Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment Nowowiejska, Julia Baran, Anna Krahel, Julita A. Kamiński, Tomasz W. Maciaszek, Magdalena Flisiak, Iwona Metabolites Brief Report Psoriasis is a common inflammatory skin disease, which is tightly associated with metabolic disorders. Cholesteryl ester transfer protein (CETP) and sortilin (SORT) are molecules engaged in lipid metabolism of proatherogenic properties. They have been hardly ever studied in psoriasis before. Serum CETP and SORT concentrations were measured in 33 patients with plaque-type psoriasis before and after 12 weeks of treatment with methotrexate or acitretin. There was no significant difference in CEPT and SORT serum concentrations between patients and controls. Positive correlations between CETP after the treatment with acitretin and activity of transaminases (R = 0.65, R = 0.56, respectively) were noted. CETP was positively related with triglycerides (R = 0.49), glucose (R = 0.54) and CRP (R = 0.64) before the treatment with methotrexate, which all disappeared afterwards. Systemic therapy with methotrexate caused normalization of SORT concentration. There was significant correlation between SORT and WBC (p < 0.01) and CRP (p < 0.05). CETP and SORT cannot be used as individual biomarkers. Nevertheless, they show some interesting relations with other parameters. Increased concentration of CETP perhaps could investigated as a marker of liver side effects of acitretin treatment in psoriatics. SORT could be considered as a new indicator of metabolically induced inflammation in psoriasis. Methotrexate may be preferred in patients with high SORT concentrations. Further studies are needed to establish their exact role in psoriatic patients. MDPI 2022-04-09 /pmc/articles/PMC9032539/ /pubmed/35448527 http://dx.doi.org/10.3390/metabo12040340 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Brief Report
Nowowiejska, Julia
Baran, Anna
Krahel, Julita A.
Kamiński, Tomasz W.
Maciaszek, Magdalena
Flisiak, Iwona
Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
title Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
title_full Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
title_fullStr Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
title_full_unstemmed Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
title_short Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment
title_sort serum cholesteryl ester transfer protein (cetp) and sortilin (sort) in patients with psoriasis with relation to systemic treatment
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9032539/
https://www.ncbi.nlm.nih.gov/pubmed/35448527
http://dx.doi.org/10.3390/metabo12040340
work_keys_str_mv AT nowowiejskajulia serumcholesterylestertransferproteincetpandsortilinsortinpatientswithpsoriasiswithrelationtosystemictreatment
AT barananna serumcholesterylestertransferproteincetpandsortilinsortinpatientswithpsoriasiswithrelationtosystemictreatment
AT kraheljulitaa serumcholesterylestertransferproteincetpandsortilinsortinpatientswithpsoriasiswithrelationtosystemictreatment
AT kaminskitomaszw serumcholesterylestertransferproteincetpandsortilinsortinpatientswithpsoriasiswithrelationtosystemictreatment
AT maciaszekmagdalena serumcholesterylestertransferproteincetpandsortilinsortinpatientswithpsoriasiswithrelationtosystemictreatment
AT flisiakiwona serumcholesterylestertransferproteincetpandsortilinsortinpatientswithpsoriasiswithrelationtosystemictreatment